Cargando…
Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
Autores principales: | Mandal, Subrata, Sinha, Subijay, Abbas, Zahir, Venkatesh, Pradeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129778/ https://www.ncbi.nlm.nih.gov/pubmed/21666337 http://dx.doi.org/10.4103/0301-4738.82021 |
Ejemplares similares
-
Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011) -
Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis
por: Chen, Guohai, et al.
Publicado: (2017) -
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018) -
The Association between Choroidal Thickness Variations and Response to Intravitreal Bevacizumab in Central Serous Chorioretinopathy
por: Kim, Dong Yoon, et al.
Publicado: (2015)